Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

RUSAN PHARMA LIMITED

Active

RUSAN PHARMA LIMITED having CIN U24230MH1994PLC077069 is 31 years , 2 month & 23 days old Public Indian Company incorporated on 15 Mar 1994. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 50,000,000 and its paid up capital is Rs. 48,410,400. It's NIC code is 24230 (which is part of its CIN).

As per the NIC code, it is involved in . RUSAN PHARMA LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-29-2023. Directors of RUSAN PHARMA LIMITED are Balasaheb Annasaheb Patil and Sandeep Verma.

RUSAN PHARMA LIMITED ' Corporate Identification Number (CIN) is U24230MH1994PLC077069 and its registration number is 077069. Users may contact RUSAN PHARMA LIMITED on its Email address - ashok.sharma@rusanpharma.com Registered address of RUSAN PHARMA LIMITED is 58-D, Government Industrial Estate Charkop, Kandivali West,Mumbai,Maharashtra,India-400067. Current status of RUSAN PHARMA LIMITED is - Active.

Key Indicators

Authorised Capital
50,000,000

as on 07/06/2025

Paid Up Capital
48,410,400

as on 07/06/2025

Company Age
31 Year, 2 Months
Last Filing with ROC
1 Year, 8 Months

Company Information

CIN U24230MH1994PLC077069
Company Status Active
Registration Number 077069
Date of Incorporation 03/15/1994
RoC ROC Mumbai
Company Age 31 years & 92 days
Authorized Capital ₹ 50000000
Paid-up capital ₹ 48410400
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Public
Activity
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID ashok.sharma@rusanpharma.com
Address RUSAN HOUSE 58 DGOVT INDL ESTATE CHARKOP KANDIVLAI (W) MUMBAI Maharashtra India 400067
Website rusanpharma.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
KUNAL NAVIN SAXENA
04/11/2023 05267911 *****0856C 2 years
Director
NAVIN SATYAPAL SAXENA
03/15/1994 00109583 *****2825G 31 years
Director
BALASAHEB ANNASAHEB PATIL
03/21/2023 00143017 *****8434J 2 years
Director
. . .
01/01/1900 ASQPR5304Q *****5304Q 125 years
Director
AAKARSH NAVIN SAXENA
02/10/2016 07432845 *****4506B 9 years
Director
SANDEEP VERMA
07/06/2023 07212506 *****8489L 1 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
NAVICARE PHARMA PRIVATE LIMITED
Active
1,00,000.00 2 Maharashtra
NAVIN SAXENA RESEARCH AND TECHNOLOGY PRIVATE LIMITED
Active
1,00,000.00 2 Maharashtra
DEPENDENCE FREE LIFE FOUNDATION
Active
0.00 2 Maharashtra
TUSCANY HOLDINGS PRIVATE LIMITED
Active
1,00,200.00 2 Maharashtra
IITK FOUNDATION FOR MEDICAL RESEARCH AND TECHNOLOGY
Active
0.00 1 Uttar Pradesh

Charges on assets

1

Others

No. of Loans: 4

Total Amount: 525,000,000.00 cr

2

Canara Bank

No. of Loans: 6

Total Amount: 2,464,300,000.00 cr

3

State Bank of India

No. of Loans: 1

Total Amount: 300,000,000.00 cr

4

STATE BANK OF INDIA

No. of Loans: 2

Total Amount: 83,400,000.00 cr

5

Syndicate Bank

No. of Loans: 1

Total Amount: 35,300,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Others 100,000,000 16 Dec, 2022 - - Open
Others 100,000,000 27 Jul, 2022 - - Open
Canara Bank Bandra Kurla Complex, Bandra East 716,300,000 20 Sep, 1994 21 Jan, 2022 - Open
Canara Bank BKC, Bandra East, Mumbai 400051 750,000,000 31 Aug, 2021 - - Open
Canara Bank Bandra Kurla Complex, Bandra East 77,000,000 20 Jul, 2020 - 01 Jan, 2024 Closed
Others Old Padra Road 165,000,000 23 May, 2020 08 Oct, 2020 - Open
Others 160,000,000 28 Dec, 2015 06 Feb, 2023 - Open
Canara Bank Bandra Kurla Complex, Bandra East 60,000,000 16 Apr, 2018 05 Jun, 2018 - Open
State Bank of India B, Wing, Nariman Point, 300,000,000 17 Oct, 2005 17 Jan, 2018 - Open
Canara Bank Bandra Kurla Complex, Bandra East 165,000,000 29 Sep, 2020 - - Open
Canara Bank NARIMAN POINT 696,000,000 06 Dec, 2001 20 Dec, 2010 04 Jul, 2015 Closed
STATE BANK OF INDIA WORLD TRADE CENTRE, CUFFE PARADE 82,500,000 05 Aug, 2007 06 Aug, 2007 - Open
Syndicate Bank Borivali West 35,300,000 28 Jun, 2016 - 30 Jan, 2024 Closed
STATE BANK OF INDIA 4,CONVENT ROAD 900,000 19 Feb, 2010 - - Open

Registered Details

CIN
U24230MH1994PLC077069
PAN
U24230MH1994PLC077069
Incorporation
1 years , 11 month
Company Email
ashok.sharma@rusanpharma.com
Paid up Capital
₹ 48,410,400
Authorised Capital
₹ 50,000,000
Type
Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Rusan Pharma Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Rusan Pharma Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Rusan Pharma Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Rusan Pharma Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Rusan Pharma Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Rusan Pharma Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Rusan Pharma Limited

What is RUSAN PHARMA LIMITED ?

RUSAN PHARMA LIMITED having CIN U24230MH1994PLC077069 is 1 years , 11 month old Public Indian Company incorporated with MCA on 06 Jul 2023. RUSAN PHARMA LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 50,000,000 and paid-up capital is 48,410,400.

What is the CIN of RUSAN PHARMA LIMITED?

CIN of RUSAN PHARMA LIMITED is U24230MH1994PLC077069.

Where is RUSAN PHARMA LIMITED located?

Address of RUSAN PHARMA LIMITED is 58-d, government industrial estate charkop, kandivali west,mumbai,maharashtra,india-400067,.

Who are the directors of RUSAN PHARMA LIMITED ?

The company has 8 directors/key management personnel Kunal Saxena,navin Saxena,balasaheb Patil,. .,aakarsh Saxena,balasaheb Patil,kunal Saxena,sandeep Verma,

What is the contact details of RUSAN PHARMA LIMITED ?

Email : ashok.sharma@rusanpharma.com
Address : RUSAN HOUSE 58 DGOVT INDL ESTATE CHARKOP KANDIVLAI (W) MUMBAI Maharashtra India 400067

What does RUSAN PHARMA LIMITED do?

RUSAN PHARMA LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry